ARCHIVES

ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay

This article is from The Cancer Letter archive.

Vol. 35 No. 28 | July 17, 2009

Download PDF Visit The Full Archive

Related Articles

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996

Abstracts Of Papers From Gynecologic Oncology Conference

October 10, 1975

AHCPR Invites Ideas for Outcomes Research

June 7, 1996

McCormick President-Elect of AACR; Garber To Start Term As President

March 25, 2011

Study Finds Long-Term Remission In NHL With Tositumomab, Iodine I 131 With CHOP

December 30, 2005

NCCS Networker Volume 3 Issue 4, Fall 1989

September 13, 1989